CLINICAL_TRIALS
trial_result
· 2016-03-31
Clinical Trial Update: (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy [Phase 3]
Summary
Phase 3 ACORD study evaluating NeoRecormon (epoetin beta) in patients with early diabetic nephropathy-associated anemia; results were posted following completio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-31